Hellman & Friedman Acquires Cordis from Cardinal Health
August 2, 2021
Hellman & Friedman has completed the acquisition of Cardinal Health’s Cordis business for approximately $1 billion, with the buyer assuming certain liabilities and Cardinal Health retaining certain working capital accounts. Ajax Health and Zeus Health are partnering with H&F on the transaction; Cordis will operate as an independent medical device company headquartered in Miami Lakes, Florida.
- Buyers
- Hellman & Friedman, Ajax Health, Zeus Health
- Targets
- Cordis
- Sellers
- Cardinal Health
- Industry
- Medical Devices
- Location
- Florida, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Novo Nordisk to Acquire Cardior Pharmaceuticals for Up to €1.025 Billion
March 25, 2024
Biotechnology
Novo Nordisk agreed to acquire Cardior Pharmaceuticals for up to €1.025 billion, consisting of an upfront payment plus additional milestone payments tied to development and commercial progress. The deal is expected to strengthen Novo Nordisk’s cardiovascular pipeline, centered on Cardior’s lead candidate CDR132L in phase 2 heart failure trials.
-
Cardinal Health Acquires Specialty Networks from Linden Capital for $1.2B
January 31, 2024
Healthcare Services
Cardinal Health has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization, from Linden Capital Partners for $1.2 billion in cash. The deal adds Specialty Networks' GPOs, PPS Analytics platform and life-sciences/research capabilities to Cardinal Health's Specialty business to accelerate capability expansion across urology, gastroenterology and rheumatology.
-
Cordis Acquires MedAlliance
October 17, 2022
Medical Devices
Cordis, the interventional cardiovascular device company, announced the acquisition of Switzerland-based MedAlliance, developer of the SELUTION SLR sirolimus drug‑eluting balloon. The deal includes an initial $35M investment, $200M payable at closing (expected 2023), plus up to $125M in regulatory milestones and up to $775M in commercial milestones through 2029; Cordis will begin co-promotion of SELUTION SLR in markets where it is available.
-
Hellman & Friedman and Bain Capital Acquire athenahealth for $17 Billion
February 15, 2022
Cloud & SaaS
Affiliates of Hellman & Friedman and Bain Capital completed the $17 billion acquisition of athenahealth from Veritas Capital and Evergreen Coast Capital. The deal brings in additional coinvestors (including an affiliate of GIC and a subsidiary of ADIA) while Veritas and Evergreen each retain minority investments as the buyers look to scale athenahealth's cloud-based healthcare SaaS platform.
-
ARES (Highlander Partners Portfolio Company) Acquires Cardiomed Cluj
December 22, 2021
Healthcare Services
ARES, a leading Romanian interventional cardiology operator controlled by Highlander Partners, has acquired Cardiomed Cluj to create an integrated cardiology platform in Cluj-Napoca. The deal brings Cardiomed’s large outpatient and imaging capabilities into the ARES network to expand early diagnosis, imaging and interventional cardiology services; Cardiomed founder Dr. Carmen Mureșan will continue to lead the business.
-
Haemonetics Acquires Cardiva Medical
January 20, 2021
Medical Devices
Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.